The UK NICE has issued final guidance endorsing Boehringer Ingelheim’s tenectepl...
Dren Bio has entered a strategic partnership with Novartis Pharma to develop the...
Telix is eyeing an expansion of the diagnostic imaging indications for its asset...
Final podcast in Sterling's series, examining how a range of factors influence t...
Agilent Technologies has announced a definitive agreement for the acquisition of...
Samsung Bioepis has announced the approval of EPYSQLI BLA by the US Food and Dru...
Johnson & Johnson is seeking approval for SPRAVATO for treatment-resistant depre...
Grünenthal has announced the acquisition of Valinor Pharma and its opioid-induce...
UNAIDS executive director Winnie Byanyima called upon Gilead to allow generics t...
The latest resubmission addressed remaining CMC concerns, with the FDA confirmin...
The US government will not give bluebird bio the opportunity to offer fertility ...
A Phase II trial with Johnson and Johnson (J&J) and Addex’s epilepsy drug had fa...
Access and buy GlobalData’s databook on the latest filings and grants activity f...
Access and buy GlobalData’s databook on the latest filings and grants activity f...
Access and buy GlobalData’s databook on the latest filings and grants activity f...
Access and buy GlobalData’s databook on the latest filings and grants activity f...
